Recall: D-0095-2024

Class II - Potentially Harmful

Class IIClassification

2023-10-20Initiated

OngoingStatus

Glenmark Pharmaceuticals Inc.,Firm

Product

Deferasirox Tablets for Oral Suspension, 500mg, 30-count bottle, Rx only, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-496-30

Reason

Failed Dissolution Specifications

Distribution

USA nationwide

Source: FDA drug enforcement report via openFDA (Voluntary: Firm initiated). If you take this product, talk to your pharmacist or doctor before stopping it.